Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Colussi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|June 26, 2026
CRISPR Gene Tagging for Illuminating Endogenous Protein DynamicsNader Afifi, Dennis Colussi, Oscar Perez-Leal
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 12, 2005
Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient miceShi-Shan Mao, Marie A Holahan, Carolyn Bailey, et al.
Analytical Biochemistry|July 5, 2003
Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitorShi-Shan Mao, Dennis Colussi, Carolyn M Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitorsWei He, Barbara Hanney, Michael R Myers, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
Journal of Medicinal Chemistry|October 20, 2023
First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive DeclineShams Ul Mahmood, Mariana Lozano Gonzalez, Sreedhar Tummalapalli, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties"Shams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 7, 2024
Novel 5-HT<sub>7</sub> receptor antagonists modulate intestinal immune responses and reduce severity of colitisYun Han Kwon, Benjamin E Blass, Huaqing Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') groupPhilippe G Nantermet, James C Barrow, Stacey R Lindsley, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|June 26, 2026
CRISPR Gene Tagging for Illuminating Endogenous Protein DynamicsNader Afifi, Dennis Colussi, Oscar Perez-Leal
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 12, 2005
Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient miceShi-Shan Mao, Marie A Holahan, Carolyn Bailey, et al.
Analytical Biochemistry|July 5, 2003
Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitorShi-Shan Mao, Dennis Colussi, Carolyn M Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitorsWei He, Barbara Hanney, Michael R Myers, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
Journal of Medicinal Chemistry|October 20, 2023
First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive DeclineShams Ul Mahmood, Mariana Lozano Gonzalez, Sreedhar Tummalapalli, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties"Shams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 7, 2024
Novel 5-HT<sub>7</sub> receptor antagonists modulate intestinal immune responses and reduce severity of colitisYun Han Kwon, Benjamin E Blass, Huaqing Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') groupPhilippe G Nantermet, James C Barrow, Stacey R Lindsley, et al.
Pageof 3